SCHEMBL3945941

SCHEMBL3945941

CN1CCN(c2ccc(CNC(=O)c3nn(OC(=O)c4n[nH]cc4-c4ccccc4)cc3-c3ccccc3)cc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.44
FLT3 P36888 5/20 0.43
KDR P35968 4/20 0.43
FLT1 P17948 3/20 0.43
AURKA O14965 3/20 0.42
KMT2A Q03164 1/20 0.42
SIRT6 Q8N6T7 1/20 0.40
MAPK14 Q16539 1/20 0.40
HTR6 P50406 1/20 0.40
KDM1A O60341 1/20 0.40
HDAC1 Q13547 1/20 0.40
GFER P55789 1/20 0.39
CLK1 P49759 1/20 0.39
DYRK1A Q13627 1/20 0.39
GBA1 P04062 1/20 0.38
EGFR P00533 1/20 0.38
TACR1 P25103 1/20 0.38
PRKD1 Q15139 1/20 0.37
HDAC8 Q9BY41 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL953774 0.88 ACE2 (0.53) ACE2FLT3KDRFLT1AURKA
SCHEMBL3945944 0.85 ACE2 (0.50) ACE2FLT3KDRFLT1AURKA
SCHEMBL4441493 0.83 EGFR (0.49) ACE2FLT3KDRFLT1AURKA
SCHEMBL955617 0.78 ACE2 (0.48) ACE2FLT3KDRFLT1AURKA
SCHEMBL954427 0.77 MAPT (0.55) ACE2FLT3KDRFLT1AURKA
SCHEMBL3941655 0.73 KDR (0.42) ACE2FLT3KDRFLT1AURKA
SCHEMBL3941658 0.72 KMT2A (0.41) ACE2FLT3KDRFLT1AURKA
SCHEMBL955230 0.71 ACE2 (0.48) ACE2FLT3KDRFLT1AURKA
SCHEMBL8225257 0.69 ACE2 (0.50) ACE2FLT3KDRFLT1AURKA
SCHEMBL28986003 0.68 HDAC3 (0.48) FLT3KDRFLT1AURKAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046327-A1 MEDICAL USE OF CYCLIN DEPENDENT KINASES INHIBITORS Astex Therapeutics Limited (GB) 2009-04-15 EP disclosed
EP-2046330-A2 PHARMACEUTICAL COMBINATIONS Astex Therapeutics Limited (GB) 2009-04-15 EP disclosed
WO-2008009954-A1 MEDICAL USE OF CYCLIN DEPENDENT KINASES INHIBITORS ASTEX THERAPEUTICS LIMITED (GB) 2008-01-24 WO disclosed
WO-2008007122-A2 COMBINATIONS OF PYRAZOLE DERIVATIVES FOR THE INHIBITION OF CDKS AND GSK'S ASTEX THERAPEUTICS LIMITED (GB) 2008-01-17 WO disclosed